GRAL MEDICAL
30 articole · RSS
Gral Medical 1H Turnover Up 12% To RON53M
Romanian private healthcare provider Gral Medical reported a turnover of RON53 million in the first six months of the year, up 12% compared with January-June 2014, supported by the results o...
Gral Medical Opens Two New Clinics In Over EUR1.5M Investment
Romanian private healthcare provider Gral Medical has opened two new clinics this year, in capital Bucharest and in Ploiesti, through an investment worth over EUR1.5 million, and plans to in...
Gral Medical: Healthcare Investment Spree Is Over In Romania
Another two surgery rooms could be added in 2015 in hospital OncoFort opened last year in the wake of investments worth EUR7 million, says Robert Serban, who, together with his wife Georgeta...
Gral Medical 1H Turnover Rises 18% To RON47M
Romanian private healthcare provider Gral Medical on Monday said its first-half turnover rose 18% to 47 million lei (EUR11.4 million), helped by a 35% increase in the oncology segment.
Gral Medical Eyes 20% Revenue Hike In 2014
Romanian private healthcare provider Gral Medical targets 20% higher revenues in 2014, despite the contracting of the medical service market, the company said in a statement Tuesday.
Gral Medical Opens Its First Hospital In EUR7M Investment
Romanian private healthcare provider Gral Medical has opened its first hospital, OncoFort, in a EUR7 million investment, the company said Monday.
Gral Medical 1Q Revenues Up 26% On Year, To RON18.6M
Romanian private healthcare provider Gral Medical said its first-quarter revenues rose 26% on the year to 18.6 million lei (EUR4.31 million) and estimates a 17% increase to RON88 million in...
Gral To Open Its First Private Hospital In 2H/2013
Romanian private healthcare provider Gral Medical said it will open a hospital in Bucharest in the second half of the year.
Gral Medical Buys Policlinic For EUR8,200
Romanian private healthcare provider Gral Medical buys Sibiu-based policlinic Sanostar for EUR8,200 from Genzen and Sorin Ovidiu Rotariu, according to a decision of Sanostar stockholders.